A carregar...

LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase

INTRODUCTION: LY3045697 is a potent and selective aldosterone synthase (CYP11B2) inhibitor that was developed as a safer alternative to mineralocorticoid receptor antagonists. Effects of LY3045697 on aldosterone and cortisol synthesis, as well as potassium ion homeostasis, were evaluated in two clin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Renin Angiotensin Aldosterone Syst
Main Authors: Sloan-Lancaster, Joanne, Raddad, Eyas, Flynt, Amy, Jin, Yan, Voelker, James, Miller, Jeffrey W
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5843917/
https://ncbi.nlm.nih.gov/pubmed/28814143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1470320317717883
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!